NARG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.352030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.620000E-01
Normal-vs-Stage2
1.162960E-01
Normal-vs-Stage3
1.220970E-01
Normal-vs-Stage4
4.834000E-01
Stage1-vs-Stage2
2.179000E-01
Stage1-vs-Stage3
5.597700E-03
Stage1-vs-Stage4
7.186600E-01
Stage2-vs-Stage3
3.16590000004613E-06
Stage2-vs-Stage4
5.318600E-01
Stage3-vs-Stage4
5.306300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.386790E-01
Normal-vs-AfricanAmerican
2.778200E-01
Normal-vs-Asian
1.193980E-01
Caucasian-vs-AfricanAmerican
9.091800E-01
Caucasian-vs-Asian
1.635640E-01
AfricanAmerican-vs-Asian
3.883800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.501900E-02
Normal-vs-Female
2.125400E-01
Male-vs-Female
3.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.435200E-01
Normal-vs-Age(41-60Yrs)
2.821600E-01
Normal-vs-Age(61-80Yrs)
9.922200E-02
Normal-vs-Age(81-100Yrs)
1.080370E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.295400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.310200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.764970E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.552000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.350600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.011400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.331600E-02
Normal-vs-Daily Drinker
2.789500E-02
Normal-vs-Weekly Drinker
8.059500E-02
Normal-vs-Occasional Drinker
4.424400E-01
Normal-vs-Social Drinker
5.888000E-01
Non Drinker-vs-Daily Drinker
3.011600E-01
Non Drinker-vs-Weekly Drinker
7.117000E-01
Non Drinker-vs-Occasional Drinker
8.795700E-02
Non Drinker-vs-Social Drinker
1.160220E-01
Daily Drinker-vs-Weekly Drinker
6.437400E-01
Daily Drinker-vs-Occasional Drinker
2.616200E-02
Daily Drinker-vs-Social Drinker
2.262300E-02
Weekly Drinker-vs-Occasional Drinker
1.254990E-01
Weekly Drinker-vs-Social Drinker
1.065630E-01
Occasional Drinker-vs-Social Drinker
7.929600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.641950E-01
Normal-vs-Grade 2
7.823800E-02
Normal-vs-Grade 3
5.643900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.845000E-01
Grade 1-vs-Grade 3
7.954000E-01
Grade 1-vs-Grade 4
1.641950E-01
Grade 2-vs-Grade 3
4.706000E-01
Grade 2-vs-Grade 4
7.823800E-02
Grade 3-vs-Grade 4
5.643900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.907900E-02
Normal-vs-NonDiabetic
1.220800E-01
Diabetic-vs-NonDiabetic
2.660200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.931800E-02
Normal-vs-NoPancreatitis
1.181590E-01
Pancreatitis-vs-NoPancreatitis
5.089800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.860580E-01
Normal-vs-N1
1.291990E-01
N0-vs-N1
9.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.673600E-01
Normal-vs-TP53-NonMutant
4.818200E-01
TP53-Mutant-vs-TP53-NonMutant
3.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
